{"nct_id":"NCT00723983","title":"Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period","status":"COMPLETED","status_verified_date":"2016-02","start_date":"2008-11","start_date_type":null,"primary_completion_date":"2009-09","primary_completion_date_type":"ACTUAL","completion_date":"2009-09","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TEVA"]}